The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“during the past two decades, the research team at the NCTR has produced several drug-induced toxicity benchmark datasets by manually reading and analyzing drug labeling documents, such as those for drug-induced liver injury (DILI) [9–11], drug-induced cardiotoxicity (DICT) [12], drug-induced renal injury list (DIRIL) [13], and others”
From Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabel (2025) · cites this paper as [10]
Citations
Cites
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 505
Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
Lewis, W., Day, B. J., & Copeland, W. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1201 · Cited by 496
In vitro models for liver toxicity testing
Soldatow, V. Y., LeCluyse, E. L., Griffith, L. G., & Rusyn, I. (2012) · Toxicology Research · doi:10.1039/c2tx20051a · Cited by 482
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406
Self-citationLammert, C. S., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E. S., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22272 · Cited by 389
Cited by
Sorted by citations
Items 101–200 of 400
Wijaya, L. S., Trairatphisan, P., Gábor, A., Niemeijer, M., Keet, J., Morera, A. A., Snijders, K. E., Wink, S., Yang, H., Schildknecht, S., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114591 · Cited by 27
Development of an AI model for DILI-level prediction using liver organoid brightfield images
Tan, S., Ding, Y., Wang, W., Rao, J., Cheng, F., Zhang, Q., Xu, T., Hu, T., Hu, Q., Ye, Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08205-6 · Cited by 26
Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug‐Induced Liver Injury
Yang, Q., Zhang, S., & Li, Y. (2024) · Toxicology · doi:10.1016/j.tox.2024.153736 · Cited by 27
Khan, M. Z. I., Ren, J.-N., Cao, C., Ye, H.-Y.-X., Wang, H., Guo, Y.-M., Yang, J., & Chen, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1441587 · Cited by 31
Su, R., Wu, H., Liu, X., & Wei, L. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz165 · Cited by 27
Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury
Shimizu, Y., Sasaki, T., Yonekawa, E., Yamazaki, H., Ogura, R., WATANABE, M., Hosaka, T., Shizu, R., Takeshita, J., & Yoshinari, K. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.167 · Cited by 26
ChemBioSim: Enhancing Conformal Prediction of In Vivo Toxicity by Use of Predicted Bioactivities
de Lomana, M. G., Morger, A., Norinder, U., Buesen, R., Landsiedel, R., Volkamer, A., Kirchmair, J., & Mathea, M. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00451 · Cited by 25
Kang, M.-G., & Kang, N. S. (2021) · Molecules · doi:10.3390/molecules26247548 · Cited by 29
Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management
Li, S., Xu, Z., Guo, M., Li, M., & Wen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.009 · Cited by 25
Recent Advances in Toxicity Prediction: Applications of Deep Graph Learning
Miao, Y., Ma, H., & Huang, J. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00384 · Cited by 29
Segovia‐Zafra, A., Paz, M. V., Serras, A. S., Matilla‐Cabello, G., Bodoque-García, A., Zeo-Sánchez, D. E. D., Niu, H., Álvarez‐Álvarez, I., Sanz‐Villanueva, L., Godec, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.026 · Cited by 24
Fäs, L., Chen, M., Tong, W., Wenz, F., Hewitt, N. J., Tu, M., Sanchez, K., Zapiórkowska-Blumer, N., Varga, H., Kaczmarska, K., et al. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae123 · Cited by 25
Self-citationAssessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression Analysis
Lejal, V., Cerisier, N., Rouquié, D., & Taboureau, O. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00381 · Cited by 24
Oda, S., Uchida, Y., Aleo, M. D., Koza‐Taylor, P., Matsui, Y., Hizue, M., Marroquin, L. D., Whritenour, J., Uchida, E., & Yokoi, T. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02882-4 · Cited by 22
Investigating ADR mechanisms with Explainable AI: a feasibility study with knowledge graph mining
Bresso, E., Monnin, P., Cédric Bousquet, B., Calvier, F.-É., Ndiaye, N. C., Petitpain, N., Smaïl‐Tabbone, M., & Coulet, A. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01518-6 · Cited by 23
Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors
Adeluwa, T., McGregor, B. A., Guo, K., & Hur, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648805 · Cited by 24
Toxicity prediction using target, interactome, and pathway profiles as descriptors
Füzi, B., Mathai, N., Kirchmair, J., & Ecker, G. F. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.04.005 · Cited by 22
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 21
Zhu, J., Chen, M., Borlak, J., & Tong, W. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02621-4 · Cited by 18
Self-citationImage-based molecular representation learning for drug development: a survey
Li, Y., Liu, B., Deng, J., Guo, Y., & Du, H. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae294 · Cited by 23
Machine Learning Models for Predicting Liver Toxicity
Liu, J., Guo, W., Sakkiah, S., Ji, Z., Yavaş, G., Zou, W., Chen, M., Tong, W., Patterson, T. A., & Hong, H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1960-5_15 · Cited by 20
Self-citationYan, B., Ye, X., Wang, J., Han, J., Wu, L., He, S., Liu, K., & Bo, X. (2022) · Molecules · doi:10.3390/molecules27103112 · Cited by 22
The safety of oral antifungals for the treatment of onychomycosis
Gupta, A. K., Haas-Neill, S., & Talukder, M. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2280137 · Cited by 20
Shin, H. K., Kang, M.-G., Park, D., Park, T., & Yoon, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00067 · Cited by 21
A large-scale human toxicogenomics resource for drug-induced liver injury prediction
Bergen, V., Kodella, K. R., Srikrishnan, S., Barrandon, O., Anderson, S., Rogers-Grazado, M., Fowler, C. C., Beyene, H., Robichaud, N., Fulton, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65690-3 · Cited by 30
Shin, H. K., Huang, R., & Chen, M. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113948 · Cited by 19
Self-citationJiang, J., van Ertvelde, J., Ertaylan, G., Peeters, R., Jennen, D. G. J., de Kok, T. M. C. M., & Vinken, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03583-4 · Cited by 23
Mostafa, F. B., Howle, V. E., & Chen, M. (2024) · Toxics · doi:10.3390/toxics12060385 · Cited by 19
Self-citationBajželj, B., & Drgan, V. (2020) · Molecules · doi:10.3390/molecules25030481 · Cited by 19
Mechanism-based integrated assay systems for the prediction of drug-induced liver injury
Kawaguchi, M., Nukaga, T., Sekine, S., Takemura, A., Susukida, T., Oeda, S., Kodama, A., Hirota, M., Kouzuki, H., & Ito, K. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114958 · Cited by 19
Zhao, C. X., Jiang, Y., Zhang, X., Zheng, R., Qiu, R., Sun, Y., Zhao, C. X., & Shang, H. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac196 · Cited by 18
Text summarization with ChatGPT for drug labeling documents
Ying, L., Liu, Z., Fang, H., Kusko, R. L., Wu, L., Harris, S., & Tong, W. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104018 · Cited by 19
Self-citationCourtois, É., Pariente, A., Salvo, F., Volatier, É., Tubert‐Bitter, P., & Ahmed, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01010 · Cited by 20
Sridharan, K., Daylami, A. A., Ajjawi, R., & Ajooz, H. A. A. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100580 · Cited by 18
Wu, L., Fang, H., Qu, Y., Xu, J., & Tong, W. (2025) · Drug Safety · doi:10.1007/s40264-025-01520-1 · Cited by 20
Self-citationNew approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
Shrimali, S., Chen, M., Li, D., & Tong, W. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104452 · Cited by 18
Self-citationThe OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment
Rouquié, D., Bender, A., Cheah, J. H., Crute, C., Dalmas, D. A., Ewald, J., Fullerton, A. M., Harrill, J., Kadri, S., Kleinstreuer, N., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf128 · Cited by 17
New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
Courtois, É., Tubert‐Bitter, P., & Ahmed, I. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01450-3 · Cited by 17
Consideration of predicted small-molecule metabolites in computational toxicology
de Lomana, M. G., Svensson, F., Volkamer, A., Mathea, M., & Kirchmair, J. (2022) · Digital Discovery · doi:10.1039/d1dd00018g · Cited by 17
Schöning, V., Krähenbühl, S., & Drewe, J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.10.009 · Cited by 17
Automated Integration of Structural, Biological and Metabolic Similarities to Sustain Read-Across
Gadaleta, D. (2020) · ALTEX · doi:10.14573/altex.2002281 · Cited by 17
Liu, X., Zheng, D., Zhong, Y., Xia, Z., Luo, H., & Weng, Z. (2020) · BioMed Research International · doi:10.1155/2020/4795140 · Cited by 17
An ensemble learning approach for modeling the systems biology of drug-induced injury
Aguirre‐Plans, J., Piñero, J., de Souza, T. M., Callegaro, G., Kunnen, S. J., Sanz, F., Fernández‐Fuentes, N., Furlong, L. I., Güney, E., & Oliva, B. (2021) · Biology Direct · doi:10.1186/s13062-020-00288-x · Cited by 17
Shi, X.-X., Wang, Z.-Z., Sun, X., Wang, Y., Liu, H., Wang, F., Hao, G., & Yang, G. (2023) · Green Chemistry · doi:10.1039/d2gc03973g · Cited by 16
Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity
Chung, E., Wen, X., Jia, X., Ciallella, H. L., Aleksunes, L. M., & Zhu, H. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134297 · Cited by 15
Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury
Niu, H., Álvarez‐Álvarez, I., & Chen, M. (2025) · Liver International · doi:10.1111/liv.70038 · Cited by 18
Self-citationImpact of halogenation on scaffold toxicity assessed using HD-GEM machine learning model
Boya, B. R., Lee, J., Choi, J.-M., & Lee, J. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf347 · Cited by 15
Lee, T., & Posma, J. M. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01068-3 · Cited by 19
Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes
Ewald, J., Titterton, K., Bäuerle, A., Beatson, A., Boiko, D. A., Cabrera, Á. A., Cheah, J. H., Cimini, B. A., Gorissen, B. L., Harrill, J., et al. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101566 · Cited by 19
Guan, J., Dong, D., Xie, P., Zhao, Z., Guo, Y., Lee, T.-Y., Yao, L., & Chiang, Y. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02079 · Cited by 17
Morger, A., de Lomana, M. G., Norinder, U., Svensson, F., Kirchmair, J., Mathea, M., & Volkamer, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-09309-3 · Cited by 18
ToxSTAR: drug-induced liver injury prediction tool for the web environment
Shin, H. K., Chun, H., Lee, S., Park, S., Park, D., Kang, M.-G., Hwang, S., Oh, J., Han, H., Kim, W., et al. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac490 · Cited by 14
Guo, L., Ma, J., Xiao, M., Liu, J., Hu, Z., Xia, S., Li, N., Yang, Y., Gong, H., Xi, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06993-z · Cited by 15
Identifying multiscale translational safety biomarkers using a network-based systems approach
Callegaro, G., Schimming, J. P., Piñero, J., Kunnen, S. J., Wijaya, L. S., Trairatphisan, P., van den Berk, L., Beetsma, K., Furlong, L. I., Sutherland, J. J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106094 · Cited by 14
Novel in Vitro Method Reveals Drugs That Inhibit Organic Solute Transporter Alpha/Beta (OSTα/β)
Malinen, M. M., Kauttonen, A., Beaudoin, J. J., Sjöstedt, N., Honkakoski, P., & Brouwer, K. L. R. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00966 · Cited by 14
Rathman, J. F., Yang, C., Ribeiro, J. V., Mostrąg, A., Thakkar, S., Tong, W., Hobocienski, B., Sacher, O., Magdziarz, T., & Bienfait, B. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00423 · Cited by 14
Self-citationWijaya, L. S., Gábor, A., Pot, I., van de Have, L., Sáez-Rodríguez, J., Stevens, J. L., Dévédec, S. E. L., Callegaro, G., & van de Water, B. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad121 · Cited by 17
Live-cell painting: Image-based profiling in live cells using acridine orange
Garcia-Fóssa, F., Moraes-Lacerda, T., Rodrigues-da-Silva, M., Diaz-Rohrer, B. B., Singh, S., Carpenter, A. E., Cimini, B. A., & de Jesus, M. B. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-07-0308 · Cited by 18
Linking chemicals, genes and morphological perturbations to diseases
Cerisier, N., Dafniet, B., Badel, A., & Taboureau, O. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116407 · Cited by 13
Goracci, L., Valeri, A., Sciabola, S., Aleo, M. D., Moritz, W., Lichtenberg, J., & Cruciani, G. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00364 · Cited by 13
Human Liver Organoid Models for Assessment of Drug Toxicity at the Preclinical Stage
Karabicici, M., Akbari, S., Ertem, Ö., Gümüştekin, M., & Erdal, E. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230411100121 · Cited by 12
Schöning, V., Hammann, F., Peinl, M., & Drewe, J. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx187 · Cited by 12
Wu, Y., Xiao, W., Tong, W., Borlak, J. T., & Chen, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.009 · Cited by 13
Self-citationBeyond the hype and toward application: liver complex in vitro models in preclinical drug safety
Jadalannagari, S., & Ewart, L. C. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2328794 · Cited by 11
Han, J., Zhung, W., Jang, I., Lee, J., Kang, M. J., Lee, T. D., Kwack, S. J., Kim, K., Hwang, D., Lee, B.-W., et al. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00992-8 · Cited by 16
Moein, M., Heinonen, M., Mesens, N., Chamanza, R., Amuzie, C. J., Will, Y., Ceulemans, H., Samuel Kaski, A., & Herman, D. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00378 · Cited by 12
Thakkar, S., Perkins, R., Hong, H., & Tong, W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64317-9 · Cited by 11
Self-citationAguayo‐Orozco, A., Brunak, S., & Taboureau, O. (2020) · Computational Toxicology · doi:10.1016/j.comtox.2020.100147 · Cited by 11
Transform Drug Discovery and Development With Generative Artificial Intelligence
Lavecchia, A. (2025) · Wiley eBooks · doi:10.1002/9781394280735.ch25 · Cited by 14
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study
Ortega-Vallbona, R., Palomino‐Schätzlein, M., Tolosa, L., Benfenati, E., Ecker, G. F., Gozalbes, R., & Serrano‐Candelas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011154 · Cited by 10
Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays
Rosell-Hidalgo, A., Eakins, J. A., Walker, P., Moore, A. L., & Ghafourian, T. (2023) · Biomedicines · doi:10.3390/biomedicines11123272 · Cited by 10
Mitkov, J., Kondeva-Burdina, M., & Zlatkov, A. (2019) · Pharmacia · doi:10.3897/pharmacia.66.e37263 · Cited by 10
In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk
Norona, L. M., Fullerton, A. M., Lawson, C., Leung, L., Brumm, J., Kiyota, T., Maher, J. M., Khojasteh, C., & Proctor, W. R. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02804-4 · Cited by 10
Moreno‐Torres, M., López-Pascual, E., Rapisarda, A. S., Quintás‐Cardama, A., Drees, A., Steffensen, I., Luechtefeld, T. H., Serrano‐Candelas, E., de Lomana, M. G., Gadaleta, D., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116530 · Cited by 9
Li, T., Li, J., Jiang, H., & Skiles, D. B. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03800-4 · Cited by 10
Ma, J., Chen, H., Sun, J., Huang, J., He, G., & Yang, G. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02443-8 · Cited by 10
Olubamiwa, A. O., Qu, Y., Connor, S., Tong, W., Li, D., & Chen, M. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104485 · Cited by 9
Self-citationUniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
Silberg, J., Swanson, K., Simon, E. P., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H. K., & Zou, J. (2024) · neural information processing systems · doi:10.52202/079017-0385 · Cited by 9
A scalable human liver-on-a-chip platform for predictive safety assessment
Kulkarni, G., Chen, L., Sang, J., Seo, J. H., Grall, R., Wang, Y., Gilbride, P., Yuan, Y., Albaum-Getzen, M., McCormack, J., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154378 · Cited by 11
Tan, E. H., Ling, Z. J., Ang, P. S., Sung, C., Dan, Y. Y., & Tai, B. C. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5099 · Cited by 9
Kurosaki, K., & Uesawa, Y. (2022) · The Journal of Toxicological Sciences · doi:10.2131/jts.47.89 · Cited by 10
Molecular mechanism for the involvement of CYP2E1/NF-κB axis in bedaquiline-induced hepatotoxicity
Kotwal, P., Khajuria, P., Dhiman, S., Kour, D., Dhiman, S. K., Kumar, A., & Nandi, U. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121375 · Cited by 9
Lam, C. S., Hua, R., Au-Doung, P. L. W., Wu, Y. K., Koon, H. K., Zhou, K. R., Loong, H. H.-F., Chung, V. C., & Cheung, Y. T. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.919 · Cited by 9
Utility of human cytochrome P450 inhibition data in the assessment of drug-induced liver injury
Kaito, S., Takeshita, J., Iwata, M., Sasaki, T., Hosaka, T., Shizu, R., & Yoshinari, K. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2312505 · Cited by 8
Järvinen, P. P., Kakko, M., & Sikanen, T. M. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106817 · Cited by 9
Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
Patel, S., Mendler, M. H., Valasek, M. A., & Tsunoda, S. M. (2018) · Case Reports in Transplantation · doi:10.1155/2018/7410508 · Cited by 9
Lesiński, W., Mnich, K., Golińska, A. K., & Rudnicki, W. R. (2021) · Biology Direct · doi:10.1186/s13062-020-00286-z · Cited by 9
Moore, R., Ashby, K., Liao, T.-J., & Chen, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010603 · Cited by 10
Self-citationIvanov, S. M., Lagunin, A. A., Filimonov, D. A., & Poroikov, V. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00307 · Cited by 9
Fey, S. J., Korzeniowska, B., & Wrzesinski, K. (2020) · Toxicology Research · doi:10.1093/toxres/tfaa033 · Cited by 9
Taher, M. K., Alami, A., Gravel, C. A., Tsui, D., Bjerre, L. M., Momoli, F., Mattison, D. R., & Krewski, D. R. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.1993187 · Cited by 9
Automatic text classification of drug-induced liver injury using document-term matrix and XGBoost
Chen, M., Wu, Y., Wingerd, B., Liu, Z., Xu, J., Thakkar, S., Pedersen, T. J., Donnelly, T., Mann, N., Tong, W., et al. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1401810 · Cited by 8
Self-citationTreatment of Alcohol Use Disorder
Tareen, K., Clifton, E. G., Perumalswami, P., Mellinger, J. L., & Winder, G. S. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.06.011 · Cited by 9
ToxProfiler: A novel human-based reporter assay for in vitro chemical safety assessment
ter Braak, B., Wolters, L., Elbertse, K., Østerlund, T., Hendriks, G., & Jamalpoor, A. (2024) · Toxicology · doi:10.1016/j.tox.2024.153970 · Cited by 9
Naito, Y., Yoshinouchi, Y., Sorayama, Y., Kohara, H., Kitano, S., Irie, S., & Matsusaki, M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.027 · Cited by 10
Wang, Y., & Chen, X. (2021) · Journal of Chemistry · doi:10.1155/2021/2293871 · Cited by 8
Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity
Miao, X., Dear, G. J., Beaumont, C., Vitulli, G., Collins, G. W., Gorycki, P. D., Harrell, A. W., & Sakatis, M. Z. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00402 · Cited by 8
Zhou, Y., Zhong, Y., & Lauschke, V. M. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2461484 · Cited by 8
Impacts of diphenylamine NSAID halogenation on bioactivation risks
Schleiff, M. A., Payakachat, S., Schleiff, B. M., Swamidass, S. J., Boysen, G., & Miller, G. P. (2021) · Toxicology · doi:10.1016/j.tox.2021.152832 · Cited by 8
Taher, M. K., Alami, A., Gravel, C. A., Tsui, D., Bjerre, L. M., Momoli, F., Mattison, D. R., & Krewski, D. R. (2021) · JGH Open · doi:10.1002/jgh3.12585 · Cited by 8
Metadata
- Authors
- Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W.
- Affiliations
- National Center for Toxicological Research (US)
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Tong, Weida
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 21
- Issue
- 4
- Pages
- 648-653
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2289901683
- Cited by
- 398
- References
- 48
- Citations by year
- 2026: 46 · 2025: 56 · 2024: 61 · 2023: 54 · 2022: 32 · 2021: 56 · 2020: 34 · 2019: 21 · 2018: 22 · 2017: 12 · 2016: 4
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, FDA-approved drugs, drug labeling, prediction model, hepatotoxicity
- MeSH terms
- Drug Labeling, Pharmaceutical Preparations, Humans, Risk, Databases, Factual, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review